Evaluation of renal quantitative T2* changes on MRI following administration of ferumoxytol as a T2* contrast agent

International Journal of Nanomedicine

Volumn 9, Issue 1, 2014, Pages 2101-2107

  Hedgire, Sandeep S ^a   McDermott, Shaunagh ^a   Wojtkiewicz, Gregory R ^a   Abtahi, Seyed Mahdi ^a   Harisinghani, Mukesh ^a   Gaglia, Jason L ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b JOSLIN DIABETES CENTER   (United States)

Author keywords

Ferumoxytol; Renal MRI; T2* weighted imaging; USPIO

Indexed keywords

FERUMOXYTOL; CONTRAST MEDIUM; MAGNETITE;

ADULT; AGED; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIFFUSION WEIGHTED IMAGING; DRUG DISTRIBUTION; DRUG DOSE COMPARISON; DRUG DOSE TITRATION; DRUG UPTAKE; FEMALE; HUMAN; HUMAN EXPERIMENT; KIDNEY CORTEX; KIDNEY FUNCTION; KIDNEY MEDULLA; KIDNEY PERFUSION; MALE; NORMAL HUMAN; QUANTITATIVE ANALYSIS; VERY ELDERLY; ANATOMY AND HISTOLOGY; BIOLOGICAL MODEL; CHEMISTRY; COMPUTER ASSISTED DIAGNOSIS; COMPUTER SIMULATION; DIAGNOSTIC USE; KIDNEY; KIDNEY FUNCTION TEST; METABOLIC CLEARANCE RATE; METABOLISM; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; TISSUE DISTRIBUTION; YOUNG ADULT;

ADULT; AGED; COMPUTER SIMULATION; CONTRAST MEDIA; FEMALE; FERROSOFERRIC OXIDE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; KIDNEY; KIDNEY FUNCTION TESTS; MAGNETIC RESONANCE IMAGING; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; MODELS, BIOLOGICAL; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TISSUE DISTRIBUTION; YOUNG ADULT;

EID: 84899766564     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S61460     Document Type: Article

References (20)

1. Furness PN, Rogers-Wheatley L, Harris KP. Semiautomatic quantitation of macrophages in human renal biopsy specimens in proteinuric states. J Clin Pathol. 1997; 50(2): 118-122.
2. Hauger O, Delalande C, Deminière C, et al. Nephrotoxic nephritis and obstructive nephropathy: evaluation with MR imaging enhanced with ultrasmall superparamagnetic iron oxide-preliminary findings in a rat model. Radiology. 2000; 217(3): 819-826.
3. Ye Q, Yang D, Williams M, et al. In vivo detection of acute rat renal allograft rejection by MRI with USPIO particles. Kidney Int. 2002; 61(3): 1124-1135.
4. Beckmann N, Cannet C, Fringeli-Tanner M, et al. Macrophage labeling by SPIO as an early marker of allograft chronic rejection in a rat model of kidney transplantation. Magn Reson Med. 2003; 49(3): 459-467.
5. Grenier N, Basseau F, Ries M, Tyndal B, Jones R, Moonen C. Functional MRI of the kidney. Abdom Imaging. 2003; 28(2): 164-175.
6. Jo S-K, Hu X, Kobayashi H, et al. Detection of inflammation following renal ischemia by magnetic resonance imaging. Kidney Int. 2003; 64(1): 43-51.
7. Landry R, Jacobs PM, Davis R, Shenouda M, Bolton WK. Pharmacokinetic study of ferumoxytol: a new iron replacement therapy in normal subjects and hemodialysis patients. Am J Nephrol. 2005; 25(4): 400-410.
8. Hauger O, Grenier N, Deminère C, et al. USPIO-enhanced MR imaging of macrophage infiltration in native and transplanted kidneys: initial results in humans. Eur Radiol. 2007; 17(11): 2898-2907.
9. Sigovan M, Gasper W, Alley HF, Owens CD, Saloner D. USPIO-enhanced MR angiography of arteriovenous fistulas in patients with renal failure. Radiology. 2012; 265(2): 584-590.
10. Ersoy H, Jacobs P, Kent CK, Prince MR. Blood pool MR angiography of aortic stent-graft endoleak. AJR Am J Roentgenol. 2004; 182(5): 1181-1186.
11. Anzai Y, Prince MR, Chenevert TL, et al. MR angiography with an ultrasmall superparamagnetic iron oxide blood pool agent. J Magn Reson Imaging. 1997; 7(1): 209-214.
12. Kobayashi H, Jo S-K, Kawamoto S, et al. Polyamine dendrimer-based MRI contrast agents for functional kidney imaging to diagnose acute renal failure. J Magn Reson Imaging. 2004; 20(3): 512-518.
13. Garcia-Sanz A, Rodriguez-Barbero A, Bentley MD, Ritman EL, Romero JC. Three-dimensional microcomputed tomography of renal vasculature in rats. Hypertension. 1998; 31(1 Pt 2): 440-444.
14. Boxerman JL, Hamberg LM, Rosen BR, Weisskoff RM. MR contrast due to intravascular magnetic susceptibility perturbations. Magn Reson Med. 1995; 34(4): 555-566.
15. Rasmussen SN. Intrarenal red cell and plasma volumes in the non-diuretic rat. Determination by means of 51Cr labelled red cells and 125I-gamma-M-immunoglobulin. Pflugers Arch. 1973; 342(1): 61-72.
16. Pallone TL, Robertson CR, Jamison RL. Renal medullary microcirculation. Physiol Rev. 1990; 70(3): 885-920.
17. Patschan D, Patschan S, Müller GA. Microvasculopathy in ischemic acute kidney injury: consequences and therapeutic implications. Panminerva Med. 2012; 54(1): 45-52.
18. Tolouian R, Rajabi B, Boman D, Bilbao J, Gupta A. Iron infusion and deposition in the kidney. Clin Nephrol. 2013; 79(3): 237-240.
19. Matsushita T, Kusakabe Y, Fujii H, Murase K, Yamazaki Y, Murase K. Inflammatory imaging with ultrasmall superparamagnetic iron oxide. Magn Reson Imaging. 2011; 29(2): 173-178.
20. Myllymäki JM, Honkanen TT, Syrjänen JT, et al. Severity of tubulointerstitial inflammation and prognosis in immunoglobulin A nephropathy. Kidney Int. 2007; 71(4): 343-348.